Nightingale Health Oyj

DB:7XE Stock Report

Market Cap: €182.8m

Nightingale Health Oyj Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Teemu Suna

Chief executive officer

€1.7m

Total compensation

CEO salary percentage17.3%
CEO tenure11yrs
CEO ownership4.4%
Management average tenure6yrs
Board average tenure7yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Teemu Suna's remuneration changed compared to Nightingale Health Oyj's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024€2m€291k

-€17m

Mar 31 2024n/an/a

-€18m

Dec 31 2023n/an/a

-€18m

Sep 30 2023n/an/a

-€18m

Jun 30 2023€2m€299k

-€18m

Mar 31 2023n/an/a

-€18m

Dec 31 2022n/an/a

-€19m

Sep 30 2022n/an/a

-€17m

Jun 30 2022€2m€290k

-€16m

Mar 31 2022n/an/a

-€14m

Dec 31 2021n/an/a

-€12m

Sep 30 2021n/an/a

-€11m

Jun 30 2021€776k€287k

-€10m

Compensation vs Market: Teemu's total compensation ($USD1.74M) is above average for companies of similar size in the German market ($USD899.26K).

Compensation vs Earnings: Teemu's compensation has increased whilst the company is unprofitable.

CEO

Teemu Suna (42 yo)

11yrs

Tenure

€1,684,000

Compensation

Mr. Teemu Suna is Founder at Nightingale Health Ltd. and has been its Chief Executive Officer since 2014. He is also Director at Nightingale Health Ltd.since 2021. His main work experience: Fujitsu Servic...

Leadership Team

NamePositionTenureCompensationOwnership
Teemu Suna
Founder11yrs€1.68m4.42%
€ 8.1m
Antti Kangas
Founder12yrs€24.00k8.88%
€ 16.2m
Satu Saksman
Co-Founder & COO10yrsno data1.03%
€ 1.9m
Peter Wurtz
Founder & Scientific Directorno datano data1.89%
€ 3.5m
Pasi Soininen
Founder & Laboratory Directorno datano data8.88%
€ 16.2m
Tuukka Paavola
Chief Financial Officer3.1yrsno data0.012%
€ 22.7k
Jeffrey Barrett
Chief Scientific Officer3.3yrsno data0.014%
€ 25.3k
Minja Salmio
Chief Legal Officer8yrsno data0.14%
€ 250.8k
Salla Ruosaari
Chief Research & Development Officer4yrsno data0.12%
€ 228.0k
Charles Alessi
Chief Medical Officerless than a yearno datano data
Laura Pulkkinen
Director of Business Operationsno datano datano data

6.0yrs

Average Tenure

43yo

Average Age

Experienced Management: 7XE's management team is seasoned and experienced (6 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Teemu Suna
Founder9yrs€1.68m4.42%
€ 8.1m
Antti Kangas
Founder12yrs€24.00k8.88%
€ 16.2m
Timo Soininen
Independent Director5yrs€24.00k0.95%
€ 1.7m
Leena Niemisto
Independent Chairman4yrs€24.00kno data
Ilkka Laurila
Independent Director1.8yrs€24.00k0.027%
€ 48.5k
Olli Karhi
Independent Director10yrs€24.00kno data
George Smith
Member of the Scientific Advisory Boardno datano datano data
John Danesh
Member of the Scientific Advisory Boardno datano datano data
Eline Slagboom
Members of the Scientific Advisory Boardno datano datano data
Jose Ordovas
Member of the Scientific Advisory Boardno datano datano data

7.0yrs

Average Tenure

53yo

Average Age

Experienced Board: 7XE's board of directors are considered experienced (7 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/07 15:48
End of Day Share Price 2025/01/07 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Nightingale Health Oyj is covered by 2 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Marianne PalmuInderes Oy
Antti LuiroInderes Oy